【市场】17个国谈药拟进院,独家品种霸屏

米内网
Feb 25

精彩内容近日,成都市第六人民医院发布招标公示,将组织拟引入药品生产企业遴选工作。17个新药在列,均为国谈药,涵盖化学药及生物药,既有环泊酚注射液等超10亿大品种,亦有芦比前列酮软胶囊、替戈拉生片等2025年前三季度销售额增速达三位数的高增长品种。17个新药均为国谈药,目前均已纳入国家医保乙类目录,主要集中在消化系统及代谢、神经系统、心脑血管系统等治疗领域,可见以慢病药、常见病药为主。此次拟进院的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10